Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opinion & Analysis Roche Holdings ADR RHHBY

Healthcare
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue... see more

Opinion & Analysis (OTCQX:RHHBY)

    Potential Alzheimer's therapies focus on early intervention

    Streetwise Reports December 1, 2017

    Phase 3 trial for Inovio's VGX-3100 in cervical dysplasia gets FDA go-ahead

    The Life Sciences Report June 16, 2017

    Diffusion Pharmaceuticals takes aim at brain cancer: CEO David Kalergis

    The Life Sciences Report April 1, 2016

    BTIG's Hartaj Singh's advice for biotech investors: 'hold your powder' 'til winter

    Gail Dutton October 1, 2015

    Buy biotech when there's blood on the street: Pontifax's Ran Nussbaum

    George S. Mack September 3, 2015

    Swiss Miss: Switzerland Skirts Recession, But ETFs Struggle

    Benzinga.com  August 28, 2015

    Cutting-edge devices and diagnostics deliver drugs and profits: Cantor Fitzgerald's Caroline Corner

    George S. Mack July 31, 2015

    Play the gap to profit from Australia's undervalued biotech gems: John Hester of Bell Potter Securities

    George S. Mack July 22, 2015

    Investing in the future of cancer treatment (BMY)

    Frank Curzio August 23, 2014

    Everyone gets the flu

    Marc Lichtenfeld March 6, 2013

    Cash in on the growing Chinese pharmaceutical market

    Tony D'Altorio September 10, 2010